93M-10501-54963
5 vaccinations
13 coded responses
32 check-ins
13 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 331 / FL
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Moderna
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 2 — Moderna
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Ipsilateral axillary lymphadenopathy developed Day 7 after first vaccine,PerdueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Ipsilateral Axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Intermittent pains and lymphadenopathy axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Fair · Fatigue or tiredness, NauseaFree text: Axillary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
-
2021-01-28
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Axillary lymph nofesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-04-22
- 2021-07-22
-
2021-08-20
Dose 3 — Moderna
- 2021-11-19
- 2022-02-18
-
2022-04-21
Dose 4 — Moderna
- 2022-04-21
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Paraesthesia, Pre-existing disease, Tinnitus — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Hands & feet paresthesia & ears ringing exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Survey response — days 1–6 daily, dose 4MedDRA: Pre-existing disease, Tinnitus — Feeling: Fair · Site: Swelling · Fatigue or tirednessFree text: Tinnitus exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Survey response — days 1–6 daily, dose 4MedDRA: Unevaluable event — Feeling: FairFree text: Ipsilateral axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy, Paraesthesia, Tinnitus — Feeling: GoodFree text: Persistent tinnitus and axillary lymphadenopathy Paresthesia back to baselineMedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy, Tinnitus — Feeling: GoodFree text: Same tinnitus and axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Survey response — days 1–6 daily, dose 4MedDRA: Neuropathy peripheral, Pre-existing disease, Tinnitus — Feeling: GoodFree text: Tinnitus and exacerbation of peripheral neuropathyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Survey response — day 7, dose 4MedDRA: Paraesthesia, Tinnitus — Feeling: Fair · Chills, HeadacheFree text: Persistent tinnitus left over right ear and paresthesia handsMedDRA releases: 2024-11 · check-in free text available
- 2022-05-05
- 2022-05-12
- 2022-05-21
- 2022-05-26
- 2022-06-02
- 2022-07-22
- 2022-10-20
-
2022-11-29
Dose 5 — Moderna
- 2023-06-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-21 | Moderna | |
| 3 | 2021-08-20 | Moderna | No |
| 4 | 2022-04-21 | Moderna | No |
| 5 | 2022-11-29 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Ipsilateral axillary lymphadenopathy developed Day 7 after first vaccine,Perdue
Systemic reaction (other): Axillary lymphadenopathy
Systemic reaction (other): Ipsilateral Axillary lymphadenopathy
Systemic reaction (other): Intermittent pains and lymphadenopathy axilla
Systemic reaction (other): Axillary lymph nodes
Release 2 — day 7, dose 2
Systemic reaction (other): Axillary lymph nofes
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Hands & feet paresthesia & ears ringing exacerbation
Systemic reaction (other): Tinnitus exacerbation
Systemic reaction (other): Ipsilateral axillary lymph nodes
Systemic reaction (other): Persistent tinnitus and axillary lymphadenopathy Paresthesia back to baseline
Systemic reaction (other): Same tinnitus and axillary lymphadenopathy
Systemic reaction (other): Tinnitus and exacerbation of peripheral neuropathy
Release 11 — day 7, dose 4
Systemic reaction (other): Persistent tinnitus left over right ear and paresthesia hands
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Neuropathy peripheral | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Tinnitus | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release